Tekla Life Sciences Investors Stock Price and Value Analysis

Should you buy Tekla Life Sciences Investors stock? (NYSE:HQL). Let's see how it does in our automated value investing analysis system.

  • This company has amazingly consistent growth!
  • This company has a large dividend yield!
  • This stock looks overpriced.
  • This company is less known than others.
  • This company is not making money.

Inside the HQL Numbers

HQL Price
(Tekla Life Sciences Investors stock price per share)
[?] PE Ratio versus Sector 199% higher than other Financial stocks
[?] PE Ratio versus Industry 126% higher than other Asset Management stocks
[?] Free Cash Flow Jitter 0%
[?] Dividend Yield 9%

Is Tekla Life Sciences Investors Stock on Sale?

Based on our analysis, we believe that you should not buy Tekla Life Sciences Investors right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy HQL Stock?

Does Tekla Life Sciences Investors have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.